We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis (PROGENITOR)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00694642
First Posted: June 10, 2008
Last Update Posted: August 6, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Fundación Mutua Madrileña
Information provided by (Responsible Party):
Pilar Jimenez Quevedo, Hospital San Carlos, Madrid
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)